Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fecal Microbial Transplantation for Relapsing Multiple Sclerosis
NCT04150549Phase 2Unknown
- Start
- Jun 2023
- Primary completion
- May 2025
- Modality
- Live Biotherapeutic Products
01
Overview
A Phase 2 trial of fecal microbiome transplant in multiple sclerosis (MS). Status: unknown.
02
Drugs
fecal microbiome transplant
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT04150549.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04150549.